6. Doll Like facies…
What is it ?
Transient
neonatal
cholestasis
Affected sib
with downhill
course
Hyperammonemia
(encephalopathy)
Steatosis &
cirrhosis on
biopsy
Doll like
facies
Citrin
deficiency
8. Lost to follow up
Urine metabolic screen
Sweat chloride
Plasma Chitotriosidase
Sphingomyelinase
Beta-glucosidase
Beta-galactosidase
Apr 2009 (10mo)
normal
AST/ALT: 163/84
T. protein:5.9
Albumin: 2.9
ALP:913
GGT:138
CK: 24
Lipid profile: normal
Persisting:
Doll like facies
Organomegaly
Growth failure
Jan 2012 (3 ½ yrs)
10. Urine NGRS
+
GSD
workup
negative
High
AFP
H/O Transient
neonatal
cholestasis
(not worked up
anywhere)
SGPGI
GAL1PUT& Epimerase
normal
Urine Succinylacetone normal
Liver biopsy not possible - coagulopathy
Bone Marrow : normal
Failure to thrive
Organomegaly
TB/DB: 0.5/0.1
AST/ALT: 128/60
T. Prot/ Alb: 4.6/2.0
ALP:1505
GGT: 148
INR:1.6
Oct ‘08 (~3yrs)
Craving for protein rich food
Aversion to carbohydrates/ juices
TB/DB: 0.7/0.2
AST/ALT: 156/78
T. Prot/ Alb: 5.4/1.7
ALP:930
INR:1.8
Jan ‘09
11. Liver failure!
Transient neonatal cholestasis
Urine for metabolic screen
Sphingomyelinase
Beta-glucosidase
Beta-galactosidase
normal
Liver
Transplant
D
E
A
T
H
Recurrent encephalopathy
Off and on ascites
TB/DB: 0.7/0.2
AST/ALT: 156/78
T. Prot/ Alb: 5.4/1.7
ALP:930
INR:1.8
TB/DB: 2.0/1.3
AST/ALT: 121/77
T. Prot/ Alb: 4.5/1.5
ALP:684 GGT:88
INR: 2.3
TB/DB: 14.0/8.8
AST/ALT: 225/73
T. Prot/ Alb: 5.5/1.6
ALP:515
INR: 4.4
Jan ‘09
Dec ‘09 (~4yr)
Apr ‘10 (4 ½ yr)
14. Carrier frequency of gene mutation
China (1/79)
Taiwan (1/98)
Korea (1/50)
Japan (1/69)
Frequency of homozygous mutation for
SLC25A13 gene :
1:20,000-34,000 (East Asia)
Mol Genet Metab. 2009 Jan;96(1):44-9.
Pediatr Res 2004 Oct;56(4):608-14
16. Recovery
ALF
Citrullinemia CLD
Type II
Chinese NICCD
cohort (n=26)
21 (81%) by 1 5 (19%) :
yr age
4 died, 1
LT
-
-
Retrospective
Japanese series
(n=75)
45 NICCD
30 new born
screening
2 (4.5%)
by 1yr
1 (2.2%) by
16yrs
-
Japanese NICCD
cohort (n=5)
4 recovered
by 1yr
1 LT by
2yr
-
-
Malaysian NICCD
cohort (n=11)
10 (91%)
recovery by
22mo
1 (9%)
died
Chinese
CLD (unknown
etiology) cases
(n=44)
-
-
-
21 patients
(~50%)
(20families)
Mutation+
Song et al ,Zhonghua Er Ke Za Zhi 2009 Aug;47(8):624-7.
Xing et al Zhonghua Xue Za Zhi.2010 Apr;27(2):180-5
Ohura et al J Inherit Metab Dis 2007 Apr;30(2):139-44
19. Younger Sib
Total Protein/ Albumin Sep 08:
Total Protein/ Albumin Jan 09:
Total Protein/ Albumin April 09:
Total Protein/ Albumin Jan 12:
Unexplained
Hypoproteinemia!
3.9 / 2.0
4.3 / 2.1
4.0 / 1.8
5.9 / 2.9
Feature of citrin def.
Chen HW, JPGN 47:187–192, 2008
Elder sib Oct 08
Jan 09
Dec 09
Apr 10
AST
ALT
AST/ALT
128
60
156
78
225
97
2.1
2.0
121
77
1.57
ALP
T.Protein
Albumin
1505
4.6
2.0
930
5.4
1.7
684
4.5
1.5
2.3
505
5.5
1.6
21. Journal of Pediatric Gastroenterology and Nutrition Jun 2010
21%
diagnosed
NAFLD
19 patients with
Citrullinemia II
90% steatosis
79% fibrosis
Komatsu et al, J Hepatol 2008 Nov;49(5))
Fatty livers without obesity ! BMI <20
High serum Pancreatic secretory trypsin inhibitor (PSTI) >29ng/ml
……Pancreatitis (68%) !
22. Diagnosis
Citrulline level high
60-73% : NICCD
Japanese series
90%: new born
screening
Chen HW et al, JPGN 47:187–192, 2008
Kobayashi et al Gene Reviews 2005
Tazawa et al, Mol Genetic Metabol 2004;83(3):213-9
23. Caveats in diagnosis
Literature from Chinese/Japanese articles
Natural History is unclear
Misdiagnosis as Galactosemia and Tyrosinemia
(increase galactose and tyrosine in blood, galactosuria)
Plasma amino acids
Inconsistently and varied elevation
New born screen ineffective
Normal during asymptomatic phase,
GI bleed, high protein intake
Urine GCMS:
Various nonspecific
metabolites
25. Diet recommendations
Protein : 15-20%
Fat : 50%
Carbohydrates: 30-35%
Milk : Protein (20%) Fat (50%) Carb (30%)
Avoid
High carbohydrate / Fructose
Glycerol for brain edema
26. Liver Transplant
Recurrent encephalopathy
Liver failure
Hepatocellular Carcinoma (5-8%)
Good outcome
Auxillary
Partial
Orthotropic
Kobayashi et al Gene Reviews 2005
Soo Kim, J Korean Surg Soc 2011;80:S51-54
Yazaki, Liver Transplantation, Vol 10, No 4 (April), 2004
27. All that glitters is not GOLD!
All Chubby cheeks are not GSD!
THANK YOU
28.
29. Lipids
1)compensate for
energy
2) FA inhibit hepatic
glycolysis
Urea Cycle for
ureagenesis
Protein intake
More availability of aspartate through
aspargine and pyruvate from alanine
Chubby cheeks
Citrate –malate shuttle activated: Increase of
Glycerol 3 phosphate + breakdown of citrate
(Acetyl CoA +OAA)
Hypoproteinemia (subclinical edema)
30. Unexplained concepts
• Why majority outgrow the disease?
• Any additional factors for progression to
CLD/ALF ?
• Postulation for protein craving?